Search Results - "Immunotherapy methods"

Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma

Authors: Alexey V. Danilov Swetha Kambhampati Thiruvengadam Kim Linton et al.

Source: Blood Adv
Danilov, A V, Kambhampati Thiruvengadam, S, Linton, K, Cumings, K, Chirikov, V, Mutebi, A, Bains Chawla, S, Chhibber, A, Rivas Navarro, F, Marques Gonçalves, F, Wang, A, Ding, Z, Alshreef, A, Favaro, E, Hoehn, D & Sureda, A 2025, 'Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma', Blood Advances, vol. 9, no. 15, pp. 3754-3765. https://doi.org/10.1182/bloodadvances.2024015274

Subject Terms: Adult, Male, Lymphoid Neoplasia, Lymphoma, Humanized/therapeutic use, Middle Aged, Antibodies, Treatment Outcome, Antibodies, Monoclonal, Humanized/therapeutic use, Follicular/drug therapy, Lymphoma, Follicular/drug therapy, Monoclonal, Immunotherapy/methods, Humans, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Aged

Access URL: https://research.manchester.ac.uk/en/publications/bd4baae7-1feb-4c07-b94b-fc6ae753a309
https://doi.org/10.1182/bloodadvances.2024015274

Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation

Authors: Morris, Z.S. Demaria, S. Monjazeb, A.M. et al.

Source: The Lancet. Oncology, vol. 26, no. 3, pp. e152-e170

Subject Terms: Translational Research, Biomedical, Neoplasms, Humans, Animals, Immunotherapy/methods, Neoplasms/radiotherapy, Neoplasms/immunology, Neoplasms/therapy, United States, National Cancer Institute (U.S.), Combined Modality Therapy, Immunotherapy

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/40049206
https://serval.unil.ch/notice/serval:BIB_D113BE1A4296
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_D113BE1A42967
https://serval.unil.ch/resource/serval:BIB_D113BE1A4296.P001/REF.pdf

Advancing real-world research in thoracic malignancies: learnings from the international I-O Optimise initiative

Authors: Søren Paaske Johnsen Paul Baas Jens Benn Sørensen et al.

Source: Future Oncol
Johnsen, S P, Baas, P, Sørensen, J B, Chouaid, C, Griesinger, F, Daumont, M J, Rault, C, Emanuel, G, Penrod, J R, Jacobs, H, Muwaffak, M, Schoemaker, M J, Munro, R EJ, Baskaran, D, Durand-Zaleski, I & O'Donnell, J C 2025, 'Advancing real-world research in thoracic malignancies: learnings from the international I-O Optimise initiative', Future Oncology, vol. 21, no. 7, pp. 867-878. https://doi.org/10.1080/14796694.2025.2466416

Subject Terms: Lung Neoplasms, Biomedical Research, Mesothelioma, Malignant, Lung Neoplasms/therapy, thoracic malignancies, Review, Thoracic Neoplasms, lung cancers, survival, Carcinoma, Non-Small-Cell Lung/therapy, Database, Europe, Small Cell Lung Carcinoma/therapy, non-small-cell lung cancer, mesothelioma, Carcinoma, Non-Small-Cell Lung, Immunotherapy/methods, Mesothelioma, Malignant/therapy, small-cell lung cancer, Humans, Immunotherapy, Thoracic Neoplasms/therapy, real-world evidence

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39996596
http://www.scopus.com/inward/record.url?scp=86000237400&partnerID=8YFLogxK
https://vbn.aau.dk/da/publications/44abc433-1c1e-4587-9107-ab251729c5c9
https://vbn.aau.dk/ws/files/774353458/Johnsen_et_al._2025_._Advancing_real-world_research_in_thoracic_malignancies_-_learnings_from_the_international_I-O_Optimise_initiative.pdf
https://doi.org/10.1080/14796694.2025.2466416

Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back

Authors: Mariniello, Annapaola Borgeaud, Maxime Weiner, Marc et al.

Source: BioDrugs

Subject Terms: Tumor Microenvironment / drug effects, Immune Checkpoint Inhibitors / pharmacology, Lung Neoplasms / immunology, Immune Checkpoint Inhibitors / therapeutic use, Review Article, Carcinoma, Non-Small-Cell Lung / immunology, Tumor Microenvironment / immunology, Lung Neoplasms / drug therapy, Programmed Cell Death 1 Receptor / antagonists & inhibitors, Immunotherapy / methods, Drug Resistance, Neoplasm, Animals, Humans, Carcinoma, Non-Small-Cell Lung / drug therapy

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39954220
https://archive-ouverte.unige.ch/unige:183990
https://doi.org/10.1007/s40259-024-00700-2

Evaluating the benefits of immunotherapy in metastatic cervical cancer: an observational retrospective analysis

Authors: Ana Isabel Martín-Quesada Lina Pérez-Mendez Natalia Dolores Pérez-Rodríguez

Source: Clin Transl Oncol
Clinical & translational oncology, vol. 27, no. 8, pp. 3535-3542

Subject Terms: Brief Research Article, Humans, Female, Uterine Cervical Neoplasms/pathology, Uterine Cervical Neoplasms/drug therapy, Uterine Cervical Neoplasms/mortality, Uterine Cervical Neoplasms/therapy, Retrospective Studies, Middle Aged, Aged, Immunotherapy/methods, Adult, Progression-Free Survival, Antibodies, Monoclonal, Humanized/therapeutic use, Longitudinal Studies, B7-H1 Antigen/analysis, Immune Checkpoint Inhibitors/therapeutic use, Aged, 80 and over, Antineoplastic Agents, Immunological/therapeutic use, Cervical Cancer, Immunotherapy, Metastatic, Objective-Response-Rate, Progression-Free-Survival, Real-World-Evidence, Recurrent

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39921802
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F9D31B2ABC881
https://serval.unil.ch/resource/serval:BIB_F9D31B2ABC88.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_F9D31B2ABC88

Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials: A Narrative Review of Clinical Trials

Authors: Gamrath, Lone Pedersen, Tobias Bruun Møller, Martin Vad et al.

Source: Curr Oncol Rep

Subject Terms: Dietary Fiber, Clinical Trials as Topic, Mediterranean Diet, Short-chain Fatty Acids, Review, Dietary fiber, Immune Checkpoint Inhibitors/therapeutic use, Cancer Immunotherapy, Gastrointestinal Microbiome, Diet, Neoplasms, Neoplasms/immunology, Immunotherapy/methods, Humans, Immunotherapy, Gut Microbiota, Dietary Fiber/therapeutic use, Immune Checkpoint Inhibitors

Access URL: https://pubmed.ncbi.nlm.nih.gov/39753816
https://portal.findresearcher.sdu.dk/da/publications/3041d77e-ff5a-4a62-9b0a-22f3bed3a49e
https://doi.org/10.1007/s11912-024-01622-6

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial

Authors: Lopez, Juanita Powles, Thomas Braiteh, Fadi et al.

Contributors: Lopez, Juanita Powles, Thomas Braiteh, Fadi et al.

Source: Nat Med
NATURE MEDICINE

Subject Terms: atezolizumab, Male, Adult, INCREASES, Medizin, Oncologie, VACCINE, CD8-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes/immunology, Antibodies, Monoclonal, Humanized, THERAPY, Neoplasms/pathology, Sciences de la santé humaine, Article, Antigens, Neoplasm, Neoplasms, Neoplasms/immunology, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Journal Article, Humans, HETEROGENEITY, Human health sciences, Antigens, Neoplasm/immunology, Aged, Aged, 80 and over, Cancer och onkologi, Biochemistry, Genetics and Molecular Biology (all), CTLA-4 BLOCKADE, Biology and Life Sciences, Middle Aged, CANCER, CD8-Positive T-Lymphocytes/drug effects, Neoplasms/drug therapy, Antibodies, Monoclonal, Humanized/therapeutic use, Oncology, Cancer and Oncology, CELLS, Immunotherapy/methods, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Immunotherapy, Antibodies, Monoclonal, Humanized/administration & dosage

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39762422
https://dspace.library.uu.nl/handle/1874/460017
https://hdl.handle.net/2268/328378
https://doi.org/10.1038/s41591-024-03334-7
https://biblio.ugent.be/publication/01JQNPTCN4PKBW9FWBK5R9XS5W/file/01JQNVF8RNY77SZSGTDWKT746H
http://doi.org/10.1038/s41591-024-03334-7
http://hdl.handle.net/1854/LU-01JQNPTCN4PKBW9FWBK5R9XS5W
https://biblio.ugent.be/publication/01JQNPTCN4PKBW9FWBK5R9XS5W
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-555329
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85214121815
https://www.ncbi.nlm.nih.gov/pubmed/39762422
https://doi.org/10.1038/s41591-024-03334-7

A network meta-analysis of efficacy and safety of adjuvant targeted therapy or immunotherapy in non-small cell lung cancer

Authors: Sa-Nguansai, Sunatee Rattanasiri, Sasivimol Pornsuriyasak, Prapaporn et al.

Source: Sci Rep
Sa-Nguansai, S, Rattanasiri, S, Pornsuriyasak, P, Numthavaj, P, McKay, G J, Attia, J & Thakkinstian, A 2025, 'A network meta-analysis of efficacy and safety of adjuvant targeted therapy or immunotherapy in non-small cell lung cancer', Scientific Reports, vol. 15, 21696. https://doi.org/10.1038/s41598-025-05823-2

Subject Terms: Treatment Outcome, Protein Kinase Inhibitors/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, ErbB Receptors/antagonists & inhibitors, Immunotherapy/methods, Humans, Network Meta-Analysis as Topic, name=SDG 3 - Good Health and Well-being, Lung Neoplasms/drug therapy, Molecular Targeted Therapy/methods, Article, Chemotherapy, Adjuvant/methods, Randomized Controlled Trials as Topic

File Description: application/pdf

Access URL: https://pure.qub.ac.uk/en/publications/470fbca2-94a7-49b8-b0ba-5e3fafed2560

Combination CXCR4 and PD-1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses Against Hepatocellular Carcinoma

Authors: Satoru Morita Pin-Ji Lei Kohei Shigeta et al.

Source: Cancer Immunol Res
Cancer immunology research, vol. 13, no. 2, pp. 162-170

Subject Terms: 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, Priority Brief, Animals, Dendritic Cells/immunology, Dendritic Cells/drug effects, Dendritic Cells/metabolism, Receptors, CXCR4/antagonists & inhibitors, Receptors, CXCR4/immunology, Carcinoma, Hepatocellular/immunology, Carcinoma, Hepatocellular/drug therapy, Carcinoma, Hepatocellular/pathology, Mice, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Liver Neoplasms/immunology, Liver Neoplasms/drug therapy, Liver Neoplasms/pathology, Humans, Immune Checkpoint Inhibitors/pharmacology, Tumor Microenvironment/immunology, Mice, Inbred C57BL, Cell Line, Tumor, CD8-Positive T-Lymphocytes/immunology, Immunotherapy/methods

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39514263
https://serval.unil.ch/resource/serval:BIB_CD3850EE9E31.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_CD3850EE9E31
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_CD3850EE9E318

Therapy concepts in type 1 diabetes mellitus treatment: disease modifying versus curative approaches

Authors: Sigurd Lenzen Anne Jörns

Source: J Mol Med (Berl)

Subject Terms: Diabetes Mellitus, Type 1, Insulin-Secreting Cells, Humans, Animals, Disease modifying and curative therapies, Autoimmune diseases, Humans [MeSH], Latent autoimmune diabetes in adults, Insulin-Secreting Cells/pathology [MeSH], Animals [MeSH], Immunotherapy/methods [MeSH], Type 1 diabetes mellitus, Insulin-Secreting Cells/immunology [MeSH], Review, Diabetes Mellitus, Type 1/immunology [MeSH], Diabetes Mellitus, Type 1/therapy [MeSH], Insulin-Secreting Cells/metabolism [MeSH], Immunotherapy

Access URL: https://pubmed.ncbi.nlm.nih.gov/39420138
https://repository.publisso.de/resource/frl:6503093

The Immune Microenvironment in Prostate Cancer: A Comprehensive Review

Authors: Rene Novysedlak Miray Guney Majd Al Khouri et al.

Source: Oncology
Oncology, vol. 103, no. 6, pp. 521-545

Subject Terms: Humans, Prostatic Neoplasms/immunology, Prostatic Neoplasms/pathology, Prostatic Neoplasms/therapy, Tumor Microenvironment/immunology, Male, T-Lymphocytes, Regulatory/immunology, Tumor-Associated Macrophages/immunology, Immunotherapy/methods, CD4, CD8, Immunology, Immunotherapy, Metastatic, Myeloid-derived suppressor cells, Neutrophils, Prostate tumor, T cells, Tertiary lymphoid structures, Tumor-associated macrophages, Review

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39380471
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F33B7BC8896A2
https://serval.unil.ch/resource/serval:BIB_F33B7BC8896A.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_F33B7BC8896A

KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma

Authors: Jan Budczies Eva Romanovsky Martina Kirchner et al.

Source: Br J Cancer
British journal of cancer, vol. 131, no. 3, pp. 524-533

Subject Terms: Male, Aged, 80 and over, Adult, 0301 basic medicine, Lung Neoplasms, Adenocarcinoma of Lung, Middle Aged, Prognosis, Article, Aged, 80 and over [MeSH], Aged [MeSH], Lung Neoplasms/genetics [MeSH], 692/53/2423, Cohort Studies [MeSH], Proto-Oncogene Proteins p21(ras)/genetics [MeSH], Immunotherapy/methods [MeSH], Male [MeSH], Adenocarcinoma of Lung/genetics [MeSH], 631/67/1612/1350, Lung Neoplasms/immunology [MeSH], 631/114/2415, Female [MeSH], Adenocarcinoma of Lung/drug therapy [MeSH], Mutation [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Adenocarcinoma of Lung/immunology [MeSH], Tumor Suppressor Protein p53/genetics [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], 631/208/69, Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], Lung Neoplasms/pathology [MeSH], Lung Neoplasms/drug therapy [MeSH], Adenocarcinoma of Lung/pathology [MeSH], article, Proto-Oncogene Proteins p21(ras), Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Humans, Tumor Suppressor Protein p53/genetics, Mutation, Proto-Oncogene Proteins p21(ras)/genetics, Female, Adenocarcinoma of Lung/genetics, Adenocarcinoma of Lung/drug therapy, Adenocarcinoma of Lung/immunology, Adenocarcinoma of Lung/pathology, Immune Checkpoint Inhibitors/therapeutic use, Lung Neoplasms/genetics, Lung Neoplasms/drug therapy, Lung Neoplasms/pathology, Lung Neoplasms/immunology, Aged, Biomarkers, Tumor/genetics, Immunotherapy/methods, Biomarkers, Tumor, Immunotherapy, Tumor Suppressor Protein p53, Immune Checkpoint Inhibitors

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/38866964
https://serval.unil.ch/notice/serval:BIB_0BE58CAF6E6A
https://serval.unil.ch/resource/serval:BIB_0BE58CAF6E6A.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_0BE58CAF6E6A7
https://repository.publisso.de/resource/frl:6518703

Five latent factors underlie response to immunotherapy

Authors: Joseph Usset Axel Rosendahl Huber Maria A. Andrianova et al.

Contributors: Joseph Usset Axel Rosendahl Huber Maria A. Andrianova et al.

Source: Nat Genet
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Articles publicats en revistes (Institut de Recerca Biomèdica (IRB Barcelona))
Dipòsit Digital de la UB
Nature Genetics

Subject Terms: CHEMICALS AND DRUGS::Biological Factors::Biomarkers::Biomarkers, Tumor, Cancer therapy, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores::marcadores tumorales, Immunoteràpia, Medicaments antineoplàstics - Ús terapèutic, Therapeutics, Immunotheraphy, Article, Cohort Studies, DISEASES::Neoplasms, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica, Transforming Growth Factor beta, Neoplasms, Neoplasms/immunology, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological, Genetics, Journal Article, Tumor Microenvironment, Biomarkers, Tumor, Tumor Microenvironment/immunology, Humans, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy, Immune Checkpoint Inhibitors, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia, Other subheadings::Other subheadings::Other subheadings::/drug therapy, Biochemical markers, Terapèutica, Immune Checkpoint Inhibitors/therapeutic use, Treatment Outcome, ENFERMEDADES::neoplasias, Marcadors bioquímics, Mutation, Immunotherapy/methods, Càncer - Immunoteràpia, Immunotherapy, Biomarkers, Tumor/genetics, Transforming Growth Factor beta/metabolism

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39266764
https://hdl.handle.net/11351/12234
https://hdl.handle.net/2445/217272
https://dspace.library.uu.nl/handle/1874/458268

ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells

Authors: Carretero-Iglesia, Laura Hall, Olivia J Berret, Jérémy et al.

Contributors: Carretero-Iglesia, Laura Hall, Olivia J Berret, Jérémy et al.

Source: Nat Cancer

Subject Terms: Cytotoxicity, Immunologic, ADP-ribosyl Cyclase 1 / immunology, T-Lymphocytes, Tumor Escape / drug effects, [SDV.CAN]Life Sciences [q-bio]/Cancer, Multiple Myeloma / immunology, Lymphocyte Activation / drug effects, Multiple Myeloma / drug therapy, 616.07, Lymphocyte Activation, Article, Mice, Cytotoxicity, Immunologic / drug effects, Antigens, Neoplasm, Cell Line, Tumor, T-Lymphocytes / drug effects, Animals, Humans, Tumor Escape / immunology, B-Cell Maturation Antigen, Clinical Trials as Topic, Lymphocyte Activation / immunology, T-Lymphocytes / immunology, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, ADP-ribosyl Cyclase 1, Xenograft Model Antitumor Assays, Antigens, Neoplasm / immunology, [SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology, Immunotherapy / methods, Tumor Escape, Immunotherapy, B-Cell Maturation Antigen / immunology, Multiple Myeloma

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39261676
https://ora.ox.ac.uk/objects/uuid:c3622b6e-528d-4447-a487-c45f54ddb9e6
https://doi.org/10.1038/s43018-024-00821-1

Novel immunotherapeutics against LGR5 to target multiple cancer types

Authors: Chen, Hung-Chang Mueller, Nico Stott, Katherine et al.

Contributors: Chen, Hung-Chang Mueller, Nico Stott, Katherine et al.

Source: EMBO Mol Med
EMBO Molecular Medicine, Vol 16, Iss 9, Pp 2233-2261 (2024)
Chen, H C, Mueller, N, Stott, K, Kapeni, C, Rivers, E, Sauer, C M, Beke, F, Walsh, S J, Ashman, N, O’Brien, L, Rafati Fard, A, Godsinia, A, Li, C, Joud, F, Giger, O, Zlobec, I, Olan, I, Aitken, S J, Hoare, M, Mair, R, Serrao, E, Brenton, J D, Garcia-Gimenez, A, Richardson, S E, Huntly, B, Spring, D R, Skjoedt, M O, Skjødt, K, de la Roche, M & de la Roche, M 2024, ' Novel immunotherapeutics against LGR5 to target multiple cancer types ', EMBO Molecular Medicine, vol. 16, no. 9, pp. 2233-2261 . https://doi.org/10.1038/s44321-024-00121-2

Subject Terms: Medicine (General), Immunoconjugates, QH426-470, Article, Cell Line, Receptors, G-Protein-Coupled, BiTE, Mice, R5-920, LGR5, Cell Line, Tumor, Neoplasms, Receptors, Genetics, Neoplasms/therapy, Humans, Animals, Immunoconjugates/therapeutic use, G-Protein-Coupled/metabolism, Tumor, Animal, Cancer Immunotherapeutics, CAR, 3. Good health, Disease Models, Animal, ADC, Disease Models, Immunotherapy/methods, Immunotherapy

File Description: application/pdf; application/zip; text/xml

Access URL: https://pubmed.ncbi.nlm.nih.gov/39169164
https://doaj.org/article/4df981d9b6cb481e9115536caaf2c410
https://curis.ku.dk/ws/files/449227154/Novel_immunotherapeutics.pdf

Charting cancer’s course: revealing the role of diet, exercise, and the microbiome in cancer evolution and immunotherapy response

Authors: Ana Isabel Martin-Quesada Maeve A. Hennessy Ana Cardeña Gutiérrez

Source: Clin Transl Oncol
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Italy
Clinical & translational oncology, vol. 27, no. 2, pp. 473-485

Subject Terms: 0301 basic medicine, Physical exercise, Response, Review Article, 3. Good health, sarcopenia, 03 medical and health sciences, 0302 clinical medicine, QUALITY OF LIFE, Humans, Neoplasms/immunology, Neoplasms/microbiology, Neoplasms/therapy, Immunotherapy/methods, Exercise/physiology, Diet, Quality of Life, Microbiota, Gastrointestinal Microbiome/immunology, Cancer, Immunotherapy, Microbiome, Nutrition, Quality of life, Sarcopenia, NUTRITION, IMMUNOTHERAPY

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39095683
http://hdl.handle.net/10147/645401
https://serval.unil.ch/resource/serval:BIB_97053A10BE13.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_97053A10BE13
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_97053A10BE139

Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy

Authors: Annelies C. Wauters Jari F. Scheerstra Mandy M. T. van Leent et al.

Source: Nat Nanotechnol
Nature Nanotechnology, 19, 11, pp. 1735-1744
Nature Nanotechnology

Subject Terms: 0301 basic medicine, Polymers, Nephrology - Radboud University Medical Center, Melanoma, Experimental, Spleen/metabolism, Inbred C57BL, SDG 3 – Goede gezondheid en welzijn, Article, Cell Line, Mice, 03 medical and health sciences, Polymers/chemistry, SDG 3 - Good Health and Well-being, Cell Line, Tumor, Myeloid Cells/drug effects, Animals, Humans, Myeloid Cells, Tissue Distribution, Internal Medicine - Radboud University Medical Center, Melanoma, 0303 health sciences, Tumor, Melanoma/therapy, Mice, Inbred C57BL, Immunotherapy/methods, Experimental/therapy, Immunotherapy, Spleen

Access URL: https://pubmed.ncbi.nlm.nih.gov/39085390
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/313750
https://research.tue.nl/en/publications/f23e4439-e2ab-4452-a99a-39a67dcf2a02
https://doi.org/10.1038/s41565-024-01727-w
https://repository.ubn.ru.nl//bitstream/handle/2066/313750/313750.pdf
https://hdl.handle.net/2066/313750

Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy

Authors: Langouo Fontsa, Mireille Padonou, Francine Willard-Gallo, Karen

Source: Expert Review of Clinical Immunology. 20:839-847

Subject Terms: biomarkers, Sciences bio-médicales et agricoles, Tertiary Lymphoid Structures -- immunology, Neoplasms -- immunology -- therapy, Immune Checkpoint Inhibitors -- therapeutic use, Cancer Vaccines, Cancer Vaccines -- therapeutic use -- immunology, Tumor infiltrating lymphocytes, Tumor Microenvironment -- immunology, Tertiary Lymphoid Structures, Neoplasms, Immunotherapy -- methods, Tumor Microenvironment, cancer, Humans, Animals, immunotherapy, Immunotherapy, Immune Checkpoint Inhibitors, tertiary lymphoid structures

File Description: 1 full-text file(s): application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39007892

Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma Models

Authors: Salomon, Nadja Helm, Alexander Selmi, Abderaouf et al.

Source: International journal of radiation oncology, biology, physics 119(3), 936-945 (2024). doi:10.1016/j.ijrobp.2023.12.042

Subject Terms: Cancer Vaccines: immunology, Immunotherapy: methods, Heavy Ion Radiotherapy, Colonic Neoplasms: immunology, Adenocarcinoma, Cancer Vaccines, Mice, Antigens, Neoplasm, Cell Line, Tumor, Animals, Adenocarcinoma: radiotherapy, RNA, Messenger, mRNA Vaccines: therapeutic use, Adenocarcinoma: immunology, Photons, Antigens, Neoplasm: immunology, Combined Modality Therapy, Combined Modality Therapy: methods, Mice, Inbred C57BL, Colonic Neoplasms: radiotherapy, Colonic Neoplasms, Liposomes, Cancer Vaccines: therapeutic use, Female, Heavy Ion Radiotherapy: methods, Immunotherapy, mRNA Vaccines, Photons: therapeutic use

Access URL: https://pubmed.ncbi.nlm.nih.gov/38163521
https://repository.gsi.de/record/353131

Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy

Authors: Zhijie Wu Shouguo Gao Xingmin Feng et al.

Source: Nat Commun
Nature Communications, Vol 16, Iss 1, Pp 1-21 (2025)
Wu, Z, Gao, S, Feng, X, Li, H, Sompairac, N, Jamshidi, S, Choy, D, Reis, R A D, Gao, Q, Kajigaya, S, Alemu, L, Raffo, D Q, Groarke, E M, Kordasti, S, Patel, B A & Young, N S 2025, ' Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy ', Nature Communications, vol. 16, no. 1, 5048 . https://doi.org/10.1038/s41467-025-60213-6

Subject Terms: Male, Adult, Hematopoietic Stem Cells/immunology, Science, Single-Cell Analysis/methods, Autoimmunity/immunology, T-Lymphocytes, Cytotoxic/immunology, Article, Myeloid Cells/immunology, Anemia, Aplastic/immunology, Interferon-gamma/immunology, Immunotherapy/methods, Humans, Female

File Description: application/pdf

Access URL: https://doaj.org/article/bd22edbbf63e438ea68d2fcae3df83d7
https://kclpure.kcl.ac.uk/ws/files/337191461/s41467-025-60213-6.pdf